Drug intelligence / Profile preview

gedunin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Gedunin is a naturally occurring pentacyclic triterpenoid and limonoid, mainly isolated from the neem tree (*Azadirachta indica*) and other plant species[2][8]. It has demonstrated **anticancer**, **antimalarial**, **antifungal**, and **antineoplastic** properties[2][3][8]. Gedunin acts as a **heat shock protein 90 (Hsp90) inhibitor**, inducing degradation of Hsp90-dependent client proteins, and inhibits cancer cell proliferation and metastasis[1][3][7]. It does not competitively bind ATP at the Hsp90 binding site, and its α,β-unsaturated ketone moiety is required for antiproliferative activity but does not appear to act as a Michael acceptor[1]. Studies have shown anticancer efficacy in pancreatic cancer, where gedunin blocks the **sonic hedgehog (Shh)/Gli1 signaling pathway**, epithelial-mesenchymal transition (EMT), migration, invasion, and colony formation, resulting in reduced metastasis and tumor growth in xenograft models[3]. Gedunin is under investigation for its potential as a chemotherapeutic and antimalarial agent[2][7][8].

Other names
CHEBI:659542753-30-2
02

Targets

HSP90 (Heat shock protein 90 chaperone complex)

Beyond the preview

Go deeper on gedunin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gedunin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call